Trials / Conditions / Tuberous Sclerosis Complex (TSC)

Tuberous Sclerosis Complex (TSC)

9 registered clinical trials studyying Tuberous Sclerosis Complex (TSC) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), NCT07287202	Sovargen	Phase 1 / Phase 2
Recruiting	Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505	SAPU NANO (US) LLC	Phase 1
Enrolling By Invitation	TANDem-2: Closing the Gap to Interventions for TAND NCT06879665	Vrije Universiteit Brussel	N/A
Completed	Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered D NCT06975605	GRIN Therapeutics, Inc.	Phase 1
Terminated	Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itrac NCT06965881	GRIN Therapeutics, Inc.	Phase 1
Recruiting	Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Comple NCT07403266	Oils4Cure	Phase 3
Recruiting	Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric NCT06764602	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Completed	Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous NCT00790400	Novartis Pharmaceuticals	Phase 3
Completed	Precision Medicine for Neurocutaneous Syndromes in Western China NCT07327164	West China Hospital	—